Atlas Trials

Does Caffeine Reduce Dipyridamole-Induced Protection Against Ischemia-Reperfusion Injury?

Clinical trial NCT00430170 · COMPLETED

Trial details

NCT number
NCT00430170
Sponsor
Radboud University Medical Center
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Cardiovascular DiseaseIschemia-Reperfusion Injury
Start date
2007-01-01
Primary completion
2007-03-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.